This may also be due to intratumoral heterogeneity but in breast cancer patients, steroid hormone receptor profiles were also reported to be different between pre- and post-chemotherapy [34], and similar changes in GR may occur in ESCC patients but further investigations are required for clarification. The gene discussed is NR3C1; the disease is esophageal squamous cell carcinoma.